25-NSE ยทFiled Jul 27, 2026

AVNS

AVANOS MEDICAL, INC.
NEUTRAL
Impact 5/10
Horizonimmediate Processed2mo ago SEC0000876661-26-000646
Notable filing: 25-NSE
Actionable Insight โ€ข Neutral

The merger is complete and the stock is delisted; no further trading in AVNS will occur. Shareholders who have not yet tendered should contact their broker regarding receipt of the $25.00 cash payment. The delisting is a formality with no residual market activity.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

The New York Stock Exchange filed a Form 25-NSE to delist Avanos Medical, Inc. (AVNS) following the completion of its going-private merger with A-AV MergerSub, Inc., an affiliate of American Industrial Partners. The merger closed on July 27, 2026, with each share of AVNS common stock converted into $25.00 in cash. Trading was suspended immediately, and delisting will be effective August 7, 2026.

Key Facts

  • Merger closed July 27, 2026; each share of AVNS common stock converted into $25.00 cash.
  • Trading suspended on NYSE as of July 27, 2026; delisting effective August 7, 2026.
  • Acquirer is A-AV MergerSub, Inc., a wholly-owned subsidiary of A-AV Holdco I, Inc., affiliated with investment funds advised by American Industrial Partners.
  • The filing is a procedural notification under Rule 12d2-2(a)(3) for securities that now represent only the right to receive cash.

Financial Impact

All outstanding shares of AVNS were acquired at $25.00 per share in cash, implying a total equity value of approximately $1.2B based on market cap.

share priceequity value

Risk Factors

  • No further trading opportunity; remaining unexchanged shares must be submitted for the cash consideration.
  • Potential delays in receiving cash payment if shareholder records are not updated.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0000876661-26-000646
Document: 0000876661-26-000646-index.html0000876661-26-000646
Document: 0000876661-26-000646.txt0000876661-26-000646
7 reports for AVNS
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60โ–ฒ +1.13%Apr 23, 2026
Filters
Rows
Reports for AVNS โ€” sortable, filterable
TypeNow
Jul 27, 2026
9w ago
25-NSE
NEUTRAL โ˜… 5/10
$24.99 awaiting T+5awaiting T+5โ€”โ€”
Jul 2, 2026
13w ago
8-K / DEFA14A
BULLISH โ˜… 7/10
$24.93 $24.94โ–ฒ +0.04%โ–ผ โˆ’0.89%โ€”
Jun 10, 2026
16w ago
DEFM14A
BULLISH โ˜… 8/10
$24.98 $24.87โ–ผ โˆ’0.44%โ–ผ โˆ’0.87%โ€”
May 5, 2026
21w ago
DEFA14A
NEUTRAL โ˜… 5/10
$24.72 $24.73โ–ฒ +0.04%โ–ผ โˆ’1.09%โ€”
Apr 23, 2026
23w ago
DEFA14A
BULLISH โ˜… 8/10
$24.71 $24.65โ–ผ โˆ’0.24%โ–ผ โˆ’1.72%โ€”
Apr 14, 2026
24w ago
DEFA14A
NEUTRAL โ˜… 4/10
$24.63 $24.64โ–ฒ +0.04%โ–ผ โˆ’1.35%โ€”
Feb 26, 2026
31w ago
8-K
NEUTRAL โ˜… 5/10
$14.49 $13.79โ–ผ โˆ’4.83%โ–ผ โˆ’3.70%โ€”
Showing 7 of 7

US Market Status

Market Closed โ€” Opens Mon (64h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access